FISH & SHELLFISH IMMUNOLOGY

dc.creatorRivas-Aravena, Andrea Aurora
dc.creatorFuentes, Yazmin
dc.creatorCartagena, Julio
dc.creatorBrito, Tania
dc.creatorPoggio, Veronica
dc.creatorLa Torre, José
dc.creatorMendoza, Hegaly
dc.creatorGonzález-Nilo, Fernando
dc.creatorSandino, Ana María
dc.creatorSpencer, Eugenio
dc.date2021-08-23T22:52:38Z
dc.date2022-07-08T20:34:18Z
dc.date2021-08-23T22:52:38Z
dc.date2022-07-08T20:34:18Z
dc.date2015
dc.date.accessioned2023-08-22T22:38:21Z
dc.date.available2023-08-22T22:38:21Z
dc.identifier1150901
dc.identifier1150901
dc.identifierhttps://hdl.handle.net/10533/251009
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8347786
dc.descriptionAdjuvants used in vaccine aquaculture are frequently harmful for the fish, causing melanosis, granulomas and kidney damage. Along with that, vaccines are mostly administered by injection, causing pain and stress to the fish. We used the DNA coding for the replicase of alphavirus as adjuvant (Ad) of a vaccine against ISAV. The Ad and an inactivated ISAV (V) were loaded in chitosan nanoparticles (NPs) to be administered orally to Atlantic salmon. NP-Ad was able to deliver the DNA ex vivo and in vivo. Oral administration of the NPs stimulated the expression of immune molecules, but did not stimulate the humoral response. Although the vaccination with NP-V results in a modest protection of fish against ISAV, NP-V administered together with NP-Ad caused a protection of 77%. Therefore, the DNA coding for the replicase of alphavirus could be administered orally and can potentiate the immuneprotection of a virine against infection. (C) 2015 Elsevier Ltd. All rights reserved.
dc.descriptionRegular 2015
dc.descriptionFONDECYT
dc.descriptionFONDECYT
dc.languageeng
dc.relationhandle/10533/111557
dc.relationhandle/10533/111541
dc.relationhandle/10533/108045
dc.relationhttps://doi.org/10.1016/j.fsi.2015.03.033
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsinfo:eu-repo/semantics/article
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleDevelopment of a nanoparticle-based oral vaccine for Atlantic salmon against ISAV using an alphavirus replicon as adjuvant
dc.titleFISH & SHELLFISH IMMUNOLOGY
dc.typeArticulo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución